DYN

15.4703.49%
OB

Oxana Beskrovnaya

Chief Innovation Officer

Dr. Oxana Beskrovnaya, Ph.D., was Chief Scientific Officer at Dyne Therapeutics, Inc. since June 2021. She was Senior Vice President and Head of Research at Dyne Therapeutics, Inc. since January 2020 until May 2021 & serves as it's Chief Innovation Officer since April 28, 2025. Dr. Beskrovnaya has extensive experience in musculoskeletal and renal research. She is an accomplished R&D leader with a strong track record of discovering and developing first-in-class therapeutics for rare genetic diseases. Prior to joining Dyne, she served as head of musculoskeletal and renal research in Sanofi’s rare disease and neurological unit from July 2011 to January 2020. At Sanofi, she advanced a pipeline of drug candidates using multiple therapeutic modalities, including nucleic acids, proteins and small molecules. Dr. Beskrovnaya is the author of numerous patents, invited reviews, editorials, book chapters and original research articles in major scientific journals. Dr. Beskrovnaya received her Ph.D. in genetics from Moscow Genetics Institute, followed by postdoctoral fellowship training in neuromuscular diseases at the Howard Hughes Medical Institute at the University of Iowa.

Positions